These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18986460)

  • 21. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
    Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
    Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in cutaneous lymphomas.
    Dummer R; Asagoe K; Cozzio A; Burg G; Doebbeling U; Golling P; Fujii K; Urosevic M
    J Dermatol Sci; 2007 Dec; 48(3):157-67. PubMed ID: 17964121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of primary cutaneous T-cell lymphomas.
    Slater DN
    Histopathology; 1995 Jan; 26(1):99-101. PubMed ID: 7713490
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous lymphoma: a clinically relevant classification.
    Pimpinelli N; Santucci M; Giannotti B
    Int J Dermatol; 1993 Oct; 32(10):695-700. PubMed ID: 8225705
    [No Abstract]   [Full Text] [Related]  

  • 25. [Definition, classification, clinical and histological diagnosis of cutaneous T-cell lymphomas].
    Beylot-Barry M
    Ann Dermatol Venereol; 2005 Sep; 132 Spec No 2():5S5-10. PubMed ID: 16385891
    [No Abstract]   [Full Text] [Related]  

  • 26. Keratinocyte intracellular adhesion molecule-1 (ICAM-1) in the pathogenesis of Sezary syndrome and cutaneous T cell lymphoma.
    Fine RM
    Int J Dermatol; 1990 Nov; 29(9):623-4. PubMed ID: 2272733
    [No Abstract]   [Full Text] [Related]  

  • 27. Distinct subtypes of subcutaneous T-cell lymphoma.
    Burg G; Dummer R; Nestle F
    Arch Dermatol; 1994 Aug; 130(8):1073. PubMed ID: 8053710
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-KIR3DL2 therapy in the treatment of Sézary syndrome.
    Quaglino P
    Lancet Oncol; 2019 Aug; 20(8):1048-1049. PubMed ID: 31253571
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical research in cutaneous T-cell lymphoma moving forward.
    Sterry W; Heinzerling L
    Arch Dermatol; 2008 Jun; 144(6):786-7. PubMed ID: 18559771
    [No Abstract]   [Full Text] [Related]  

  • 30. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.
    Kari L; Loboda A; Nebozhyn M; Rook AH; Vonderheid EC; Nichols C; Virok D; Chang C; Horng WH; Johnston J; Wysocka M; Showe MK; Showe LC
    J Exp Med; 2003 Jun; 197(11):1477-88. PubMed ID: 12782714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sézary syndrome.
    Kreuter A; Altmeyer P
    J Am Acad Dermatol; 2005 Dec; 53(6):1093-5. PubMed ID: 16310082
    [No Abstract]   [Full Text] [Related]  

  • 32. [Peripheral blood Sézary cells and the diagnosis of Sézary syndrome].
    Tessier-Marteau A; Le Corre Y; Gérard J; Avenel-Audran M; Geneviève F; Verret JL; Zandecki M
    Ann Biol Clin (Paris); 2008; 66(4):447-53. PubMed ID: 18725348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Item no 164: malignant lymphoma: cutaneous lymphoma].
    CEDEF
    Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome.
    Gardner JM; Introcaso CE; Nasta SD; Kim EJ; Vittorio CC; Rook AH
    J Am Acad Dermatol; 2009 Jul; 61(1):112-6. PubMed ID: 19539845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases.
    Gallardo F; García-Muret MP; Servitje O; Estrach T; Bielsa I; Salar A; Abella E; Barranco C; Pujol RM
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):639-47. PubMed ID: 19207677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine cutaneous epitheliotropic T-cell lymphoma: a review.
    Fontaine J; Bovens C; Bettenay S; Mueller RS
    Vet Comp Oncol; 2009 Mar; 7(1):1-14. PubMed ID: 19222826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCF1 and Tox define different subsets of CD4 T cells in patients with Sézary syndrome.
    Wysocka M; Jariwala N; Zhang K; Benoit B; Rook AH
    Leuk Lymphoma; 2022 Nov; 63(11):2715-2718. PubMed ID: 35679527
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
    Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
    J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo imaging of cutaneous T-cell lymphoma migration to the skin.
    Hoeller C; Richardson SK; Ng LG; Valero T; Wysocka M; Rook AH; Weninger W
    Cancer Res; 2009 Apr; 69(7):2704-8. PubMed ID: 19318575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.